pilocarpine has been researched along with levetiracetam in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (30.77) | 29.6817 |
| 2010's | 13 (50.00) | 24.3611 |
| 2020's | 5 (19.23) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brandt, C; Glien, M; Löscher, W; Potschka, H | 1 |
| Grimee, R; Klitgaard, H; Margineanu, DG; Matagne, A; Vanneste-Goemaere, J | 1 |
| Aguiar, LM; Fonteles, MM; Freitas, RM; Nascimento, VS; Nogueira, CR; Oliveira, AA; Sousa, FC; Viana, GS | 1 |
| Anderson, NJ; Slough, S; Watson, WP | 1 |
| Holmes, GL; Zhao, Q; Zhou, JL | 1 |
| Aguiar, LM; Almeida, JP; Fonseca, FN; Fonteles, MM; Freitas, RM; Júnior, HV; Nascimento, VS; Oliveira, AA; Sousa, FC; Viana, GS | 1 |
| Kaminski, RM; Klitgaard, H; Margineanu, DG; Matagne, A | 1 |
| Choi, HC; Choi, SY; Jo, SM; Kang, TC; Kim, DS; Kim, JE; Kim, YI; Song, HK | 1 |
| Choi, HC; Kang, TC; Kim, JE; Kim, YI; Lee, DS; Ryu, HJ; Song, HK | 1 |
| Abdallah, DM; Al-Shorbagy, MY; El Sayeh, BM | 1 |
| Avoli, M; Behr, C; Lévesque, M | 1 |
| Chiba, Y; Inamine, M; Ishihara, Y; Itoh, K; Kotani, M; Oshima, W; Ueno, M | 1 |
| Chen, T; Li, MQ; Liu, L; Zhang, WW | 1 |
| Kaminski, RM; Leclercq, K | 1 |
| Löscher, W; Töllner, K; Twele, F | 1 |
| Ge, YX; Lin, YY; Liu, XY; Tian, XZ | 1 |
| Auvin, S; Baud, O; Bonnin, P; Charriaut-Marlangue, C; Dupuis, N; Enderlin, J; Leger, PL; Morin, L; Perrotte, G | 1 |
| Domínguez-Valentín, AE; Hernández-Moreno, A; Orozco-Suárez, S; Rocha, L; Santana-Gómez, CE; Valle-Dorado, MG | 1 |
| Abrar, H; Amir, Q; Hanif, F; Jahan, N; Javed, A; Javed, L; Malhi, SM; Malik, AB; Zaman, U | 1 |
| Hashimoto, R; Ishihara, Y; Itoh, K; Komori, R; Kono, T; Kozawa, C; Kubo, S; Matsuo, T; Yokota-Nakatsuma, A | 1 |
| Dohgu, S; Ishihara, Y; Itoh, K; Komori, R; Matsumoto, J; Matsuo, T; Nakatani, M; Ochi, S; Takata, F; Yokota-Nakatsuma, A | 1 |
| Boison, D; D'Ambrosio, R; Eastman, C; Goodkin, HP; Klein, P; Löscher, W; Murugan, M; Purnell, B; Rotenberg, A; Rundfeldt, C | 1 |
| Katyal, J; Kumar Gupta, Y; Kumar, H | 1 |
1 review(s) available for pilocarpine and levetiracetam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
25 other study(ies) available for pilocarpine and levetiracetam
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy.
Topics: Animals; Anticonvulsants; Epilepsy, Temporal Lobe; Female; Infusion Pumps; Levetiracetam; Muscarinic Agonists; Pilocarpine; Piracetam; Rats; Rats, Wistar; Time Factors | 2002 |
Electrophysiological, neurochemical and regional effects of levetiracetam in the rat pilocarpine model of temporal lobe epilepsy.
Topics: Animals; Anticonvulsants; Aspartic Acid; Clonazepam; Electroencephalography; Epilepsy, Temporal Lobe; gamma-Aminobutyric Acid; Hippocampus; Injections, Intraperitoneal; Levetiracetam; Male; Microinjections; Phenobarbital; Pilocarpine; Piracetam; Rats; Rats, Sprague-Dawley; Valproic Acid | 2003 |
Evaluation of levetiracetam effects on pilocarpine-induced seizures: cholinergic muscarinic system involvement.
Topics: Animals; Anticonvulsants; Convulsants; Disease Models, Animal; Hippocampus; Levetiracetam; Male; Mice; Muscarinic Agonists; Oxotremorine; Pilocarpine; Piracetam; Receptors, Muscarinic; Seizures | 2005 |
In vivo characterisation of the small-conductance KCa (SK) channel activator 1-ethyl-2-benzimidazolinone (1-EBIO) as a potential anticonvulsant.
Topics: Animals; Anticonvulsants; Benzimidazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Levetiracetam; Male; Mice; Motor Activity; Pentylenetetrazole; Phenytoin; Pilocarpine; Piracetam; Seizures; Sensory Thresholds; Small-Conductance Calcium-Activated Potassium Channels | 2006 |
Effect of levetiracetam on visual-spatial memory following status epilepticus.
Topics: Animals; Anticonvulsants; Behavior, Animal; Cell Death; Disease Models, Animal; Electroencephalography; Hippocampus; Levetiracetam; Male; Maze Learning; Memory Disorders; Pilocarpine; Piracetam; Random Allocation; Rats; Rats, Sprague-Dawley; Status Epilepticus; Swimming; Water | 2007 |
Effects of levetiracetam in lipid peroxidation level, nitrite-nitrate formation and antioxidant enzymatic activity in mice brain after pilocarpine-induced seizures.
Topics: Animals; Anticonvulsants; Antioxidants; Brain; Catalase; Glutathione; Levetiracetam; Lipid Peroxidation; Male; Malondialdehyde; Mice; Nitrates; Nitrites; Pilocarpine; Piracetam; Seizures; Thiobarbituric Acid Reactive Substances | 2007 |
Effects of chronic treatment with levetiracetam on hippocampal field responses after pilocarpine-induced status epilepticus in rats.
Topics: Animals; Anticonvulsants; Dose-Response Relationship, Drug; Hippocampus; Humans; Levetiracetam; Male; Membrane Potentials; Muscarinic Agonists; Pilocarpine; Piracetam; Rats; Rats, Sprague-Dawley; Status Epilepticus | 2008 |
Levetiracetam inhibits interleukin-1 beta inflammatory responses in the hippocampus and piriform cortex of epileptic rats.
Topics: Animals; Anticonvulsants; Astrocytes; Chronic Disease; Epilepsy; Gliosis; Hippocampus; Interleukin-1beta; Levetiracetam; Male; Microglia; Olfactory Pathways; Pilocarpine; Piracetam; Rats; Rats, Sprague-Dawley; Receptors, Interleukin-1 Type I; Valproic Acid | 2010 |
The effect of levetiracetam on status epilepticus-induced neuronal death in the rat hippocampus.
Topics: Animals; Behavior, Animal; Cell Death; Diazepam; Disease Models, Animal; Drug Therapy, Combination; Fluoresceins; Hippocampus; Levetiracetam; Neurons; Pilocarpine; Piracetam; Rats; Rats, Sprague-Dawley; Status Epilepticus; Valproic Acid | 2013 |
Additional antiepileptic mechanisms of levetiracetam in lithium-pilocarpine treated rats.
Topics: Animals; Anticonvulsants; Dinoprostone; Dopamine; Glutathione; Hippocampus; Interleukin-10; Levetiracetam; Lipid Peroxidation; Lithium Chloride; Male; Nitric Oxide; Norepinephrine; Peroxidase; Pilocarpine; Piracetam; Rats; Rats, Wistar; Seizures; Tumor Necrosis Factor-alpha | 2013 |
The anti-ictogenic effects of levetiracetam are mirrored by interictal spiking and high-frequency oscillation changes in a model of temporal lobe epilepsy.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Electrodes, Implanted; Electroencephalography; Epilepsy, Temporal Lobe; Hippocampus; Levetiracetam; Male; Periodicity; Pilocarpine; Piracetam; Rats, Sprague-Dawley; Seizures; Treatment Outcome; Video Recording | 2015 |
Prevention of status epilepticus-induced brain edema and neuronal cell loss by repeated treatment with high-dose levetiracetam.
Topics: Animals; Anticonvulsants; Brain Edema; Cell Death; Disease Models, Animal; Levetiracetam; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred ICR; Muscarinic Agonists; Neurons; Pilocarpine; Piracetam; Status Epilepticus; Time Factors | 2015 |
[Protective effects of levetiracetam and simvastatin on pilocarpine-induced epilepsy in rat models].
Topics: Animals; Calpain; Disease Models, Animal; Epilepsy; Hippocampus; Levetiracetam; Pilocarpine; Piracetam; Rats; Seizures; Simvastatin | 2015 |
Status epilepticus induction has prolonged effects on the efficacy of antiepileptic drugs in the 6-Hz seizure model.
Topics: Animals; Anticonvulsants; Carbamazepine; Diazepam; Disease Models, Animal; Levetiracetam; Male; Mice; Phenytoin; Pilocarpine; Piracetam; Seizures; Status Epilepticus; Treatment Outcome | 2015 |
Evaluation of the pentylenetetrazole seizure threshold test in epileptic mice as surrogate model for drug testing against pharmacoresistant seizures.
Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Drug Resistance; Epilepsy; GABA Antagonists; Levetiracetam; Male; Mice; Pentylenetetrazole; Phenobarbital; Pilocarpine; Piracetam; Rats; Seizures; Status Epilepticus; Valproic Acid | 2016 |
Chronic treatment with levetiracetam reverses deficits in hippocampal LTP in vivo in experimental temporal lobe epilepsy rats.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocampus; Levetiracetam; Long-Term Potentiation; Male; Maze Learning; Muscarinic Agonists; Neuroprotective Agents; Pilocarpine; Piracetam; Rats; Rats, Sprague-Dawley; Spatial Memory | 2016 |
Different response to antiepileptic drugs according to the type of epileptic events in a neonatal ischemia-reperfusion model.
Topics: Animals; Animals, Newborn; Anticonvulsants; Brain; Brain Ischemia; Disease Models, Animal; Epilepsy; Female; Levetiracetam; Lithium Compounds; Male; Phenobarbital; Pilocarpine; Piracetam; Random Allocation; Rats, Wistar; Reperfusion Injury; Stroke | 2017 |
Neuroprotective effects of levetiracetam, both alone and combined with propylparaben, in the long-term consequences induced by lithium-pilocarpine status epilepticus.
Topics: Animals; Anticonvulsants; Behavior, Animal; Disease Models, Animal; Hippocampus; Levetiracetam; Lithium; Male; Neurons; Neuroprotective Agents; Parabens; Pilocarpine; Rats, Wistar; Seizures; Status Epilepticus; Time | 2018 |
Diclofenac sodium enhances the antiepileptic effect of levetiracetam in pilocarpine induced epileptic mice model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Behavior, Animal; Convulsants; Diclofenac; Drug Synergism; Epilepsy; Levetiracetam; Male; Mice; Pilocarpine; Seizures; Survival Analysis | 2021 |
Regulation of Inflammation-Related Genes through
Topics: Animals; Anticonvulsants; Disease Models, Animal; Epilepsy; Inflammation; Levetiracetam; Mice; Pilocarpine; Piracetam; Status Epilepticus | 2022 |
Levetiracetam Suppresses the Infiltration of Neutrophils and Monocytes and Downregulates Many Inflammatory Cytokines during Epileptogenesis in Pilocarpine-Induced Status Epilepticus Mice.
Topics: Animals; Anticonvulsants; Cytokines; Disease Models, Animal; Encephalitis; Levetiracetam; Mice; Monocytes; Neutrophils; Pilocarpine; Proteome; Status Epilepticus | 2022 |
Preclinical pharmacokinetics and tolerability of a novel meglumine-based parenteral solution of topiramate and topiramate combinations for treatment of status epilepticus.
Topics: Animals; Anticonvulsants; Fructose; Levetiracetam; Pilocarpine; Rats; Status Epilepticus; Topiramate | 2023 |
Effect of U50488, a selective kappa opioid receptor agonist and levetiracetam against lithium-pilocarpine-induced status epilepticus, spontaneous convulsive seizures and related cognitive impairment.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Anticonvulsants; Disease Models, Animal; Levetiracetam; Lithium; Male; Pilocarpine; Rats; Rats, Wistar; Receptors, Opioid, kappa; Seizures; Status Epilepticus | 2023 |